Newsroom

BIOVECTRA is now part of Agilent

We are pleased to officially welcome BIOVECTRA, a contract development and manufacturing organization (CDMO) that specializes in biologics and complex chemistry for targeted therapies. Learn more

Newsroom Highlights

Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results
  • Agilent Press Release
Agilent ESG Report 2023
  • Report
Meet Our Lab Stars
  • Library
Securing the World’s Water Supplies from PFAS Contamination
  • Article
Implementing AI to Streamline Chromatographic Peak Picking
  • Article
Agilent NovoCyte Opteon Supports PharmiGENE to Pioneer High-End Cell Analysis Research Platform
  • Article
DSU celebrates Agilent partnership for STEM students
  • Article
Inspiring Customer Stories
  • Library
Bridging the Gap Between Science and Medicine
  • Article
Growth Frontiers: Our Stage Reflections from the 2024 Summer Davos Forum
  • Article
DoCoLab Customer Testimonial
  • Video
A Sustainable Future: Technology’s Role in Global Risk Management
  • Article
Agilent Features
  • Article Compilation

Agilent News

Press Releases

More Press Releases

Media Coverage

More Media Coverage

Coverage Highlights

Innovation & Alliances Shaping the Future of Battery Recycling
  • Battery Technology
Glycosylation Analysis for Multispecifics
  • BioPharm International
Deep Learning Framework for Peak Detection at the Intact Level of Therapeutic Proteins
  • LCGC
Tackling Global PFAS Challenges with Sophisticated MS
  • Select Science

Agilent Market Segment Videos

Start-to-Finish PFAS Workflows
  • Environmental
Battery Materials Analysis
  • Advanced Materials
Cancer Research Solutions
  • Cancer
Hydrogen Fuel Testing
  • Chemicals and Energy

Agilent Social Media

Agilent on LinkedIn

Agilent on Instagram